Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain Imaging Biomarkers for Fibromyalgia
NCT03910010Recruiting
- Sponsor
- Nova Scotia Health
- Start
- Feb 2021
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
Randomised, single-blind trial (3 arms), sponsored by Nova Scotia Health. Primary endpoint: Pain modulation. Started Feb 2021; status: recruiting.
Beyond the preview
Go deeper on NCT03910010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03910010.